Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

BACKGROUND: Assessment of measurable residual disease (MRD) is rapidly transforming the therapeutic and prognostic landscape of a wide range of hematological malignancies. Its prognostic value in acute lymphoblastic leukemia (ALL) has been established and MRD measured at the end of induction is incr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Pavlů, Jiří, Labopin, Myriam, Niittyvuopio, Riitta, Socié, Gerard, Yakoub-Agha, Ibrahim, Wu, Depei, Remenyi, Peter, Passweg, Jakob, Beelen, Dietrich W., Aljurf, Mahmoud, Kröger, Nicolaus, Labussière-Wallet, Hélène, Perić, Zinaida, Giebel, Sebastian, Nagler, Arnon, Mohty, Mohamad
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6813121/
https://ncbi.nlm.nih.gov/pubmed/31647022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0790-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados